文献速递白血病

靶向ATP酶复合物TIP48和49的基因与化学干预损害急性髓系白血病

Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia.
PubMed 文献 · Leukemia · 2023-07-25

研究显示敲除Tip49可触发p53依赖性凋亡并在体内抑制白血病发展,新型化合物DS-4950干扰Tip48/49的ATP酶活性,在健康小鼠中耐受良好,可有效减轻肿瘤负荷并改善生存,且Tip48/49依赖性在野生型p53的非血液系统恶性肿瘤中广泛保守。

要点

  • Tip49缺失触发p53依赖性凋亡并在体内抑制白血病发展
  • DS-4950干扰Tip48/49 ATP酶活性,健康小鼠耐受良好
  • DS-4950有效减轻肿瘤负荷并改善生存

核心结论

  • Tip48/49 ATP酶在功能上是必需的,并且可作为人类癌症治疗的可靶向靶点。

研究设计与样本

  • 研究采用基因敲除和新型化合物DS-4950化学抑制两种方式靶向Tip48/49,在体内外模型及健康小鼠中评估其作用。

主要发现

  • Tip49缺失触发p53依赖性凋亡并在体内抑制白血病发展。
  • DS-4950在健康小鼠中耐受良好,并有效减轻肿瘤负荷、改善生存。
  • Tip48/49依赖性在野生型p53的非血液系统恶性肿瘤中广泛保守。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The chromatin-associated AAA+ ATPases Tip48 and Tip49 are the core components of various complexes implicated in diverse nuclear events such as DNA repair and gene regulation. Although they are frequently overexpressed in many human cancers, their functional significance remains unclear. Here, we show that loss of Tip49 triggered p53-dependent apoptosis and inhibited leukemia development in vivo. To examine the impact of chemical inhibition of this complex on leukemia, we have developed the novel compound DS-4950, which interferes with the ATPase activity of the Tip48/49. Administration of DS-4950 was well-tolerated in healthy mice, and the drug effectively reduced tumor burden and improved survival. We also provide evidence that the dependency on Tip48/49 is widely conserved in non-hematologic malignancies with wild type p53. These results demonstrated that the Tip48/49 ATPases are functionally necessary and therapeutically targetable for the treatment of human cancers.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hattori A, Takamatsu-Ichihara E, Yamamoto Y, et al. Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia. Leukemia. 2023. PMID: 37491463. doi:10.1038/s41375-023-01971-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。